# Semaglutide 2.4 mg Persistence and Questionnaire Engagement at 48 Weeks

A 191-person French cohort compared 48-week semaglutide persistence across levels of optional questionnaire engagement.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/semaglutide-persistence-digital-engagement
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Evidence

# Semaglutide 2.4 mg Persistence and Questionnaire Engagement at 48 Weeks

In one French program, 79.5% of people completing an optional assessment remained on semaglutide at 48 weeks, compared with 59.5% of nonusers.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20268 min readUpdated November 2026

Still on semaglutide at 48 weeks, by an optional questionnaire · answered before treatment began — nobody was assigned to answer it · never used it · 59.5% · partly used it · 71.9% · completed it · 79.5% · Observed association in a single-center cohort.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

Studies of [how long people stay on a GLP-1](https://buythisglp.com/research/how-long-do-people-stay-on-a-glp1) reflect different care settings. The study of [weight outcomes at a UK online clinic](https://buythisglp.com/research/do-online-glp1-clinics-work) uses recorded follow-up weights, while this study measured persistence through active prescriptions. The French study followed 191 adults with severe obesity in a structured early-access program at one French center [\[1\]](https://buythisglp.com/research/semaglutide-persistence-digital-engagement#ref-1). The program supplied semaglutide at no cost to patients.

## Who was still on treatment at 48 weeks

At week 48, 97 of 122 people who completed the optional baseline assessment remained on treatment (79.5%). The figure was 23 of 32 partial users (71.9%) and 22 of 37 nonusers (59.5%) [\[1\]](https://buythisglp.com/research/semaglutide-persistence-digital-engagement#ref-1).

Each step up in engagement was associated with higher adjusted odds of continuing treatment. The estimated odds ratio was 1.62 (95% CI 1.05 to 2.50). Participants chose how much of the assessment to complete. The study defined persistence as an active prescription at the 48-week visit.

## What a questionnaire can tell us

Research on [why people stop taking GLP-1 drugs](https://buythisglp.com/research/why-do-people-stop-taking-a-glp1) describes barriers in other settings. Here, time, language, internet access or other differences could affect both completion and persistence.

The association cannot show what would happen if a clinic assigned the questionnaire. Persistence percentages from this program may differ from those in other settings.

## Frequently asked

Did the questionnaire help people stay on treatment?

People who completed it stayed on treatment more often. The study did not randomly assign engagement, so it cannot determine whether completion helped.

## Sources

1.  \[1\] Tournayre S, et al. (2026). Digital Engagement and Predictors of Semaglutide Persistence and Weight Loss in Severe Obesity: 48-Week Observational Study Journal of Medical Internet Research. [PMID 42684246](https://www.jmir.org/2026/1/e80119/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
